의료진 2 페이지 | 서울대학교병원 핵의학과

본문 바로가기

INTRANET

핵의학과 소개

인사말 연혁 의료진 진료일정 동문 조직도 찾아오시는 길

교육

학부 대학원 전공의 고창순프로젝트

연구

연구팀 전공의/전임의 보건직

진료

영상 검사 PET 검사 검체 검사 방사성핵종 표적치료 방사성의약품
생산연구개발실

게시판

핵의학소식 마로니에 단상 FAQ

핵의학과소개

의료진

핵의학과소개

의료진

Profile

Publication

Research

윤혜원 (Hyewon Youn, Ph.D.)

전문분야 : 핵의학 / 분자영상

Total 78 / 2 page

58
- 58
- . (2015) A novel hNIS/tdTomato fusion reporter for visualizing the relationship between the cellular localization of sodium iodide symporter and its iodine uptake function under heat-shock treatment.
  
  Yeom CJ, Chung T, Youn H *, Kang KW, Lee DS, Chung J-K.
  
  Molecular Imaging 2015 Mar 14:1535-3508. PMID:25773964
57
- 57
- Subdominant H60 antigen-specific CD8 T-cell response precedes dominant H4 antigen-specific response during the initial phase of allogenic skin graft rejection.
  
  Yoo KI, Jeon JY, Nam K, Youn H , Choi EY.
  
  Exp Mol Med. 2015 Feb 13;47:e140 PMID:25676063
56
- 56
- Targeting BRG1 Chromatin Remodeler via Its Bromodomain for Enhanced Tumor Cell Radiosensitivity In Vitro and In Vivo.
  
  Kwon SJ, Lee SK, Na J, Lee SA, Lee HS, Park JH, Chung JK, Youn H *, Kwon J.
  
  Mol Cancer Ther. 2015 Feb;14(2):597-607 PMID:25504753
55
- 55
- Codon-optimized human sodium iodide symporter (opt-hNIS) as a sensitive reporter and efficient therapeutic gene.
  
  Kim YH, Youn H* , Na J, Hong K-J, Kang KW, Lee DS, Chung J-K.
  
  Theranostics 2015 Jan 1; 5(1)86-96. PMID:25553100
54
- 54
- Relationship between apoptosis imaging and 131I therapeutic effect in heterogeneous tumor cells with different NIS gene expression.
  
  Jung KO, Youn H* , Kim YH, Kim S, Park JW, Kang KW, Lee DS, Chung J-K.
  
  Mol Imaging 2015 Jan-Mar ;14:1535-3508 PMID:25431214
53
- 53
- In vivo bioluminescence imaging for viable human neural stem cells incorporated within in situ gelatin hydrogels.
  
  Hwang DW, Park KM, Shim HK, Jin Y, Oh HJ, Ph SW, Lee S, Youn H, Joung YK, Lee HJ, Kim SU, Park KD, Lee DS.
  
  EJNMMI Res 2014 Dec 4(1)61. PMID:26116122
52
- 52
- Cytoplasmic parafibromin/hCdc73 interacts with eEF1Bγ to control p53 mRNA stability, cellular apoptosis, and tumorigenesis.
  
  Jo J-H, Chung T-M, Youn H , Yoo J-Y.
  
  Nature Comm 2014 Nov12; 5:5433 PMID:25388829
51
- 51
- (2014) Lesionalized therapy beyond personalized therapy.
  
  Chung JK, Kim MJ, Youn H
  
  J Korean Med Sci 2014 Oct;29 (10):1331-2 PMID:25368484
50
- 50
- In vivo bioluminescence imaging of transplanted mesenchymal stem cells as a potential source for pancreatic regeneration.
  
  Lee S, Youn H* , Chung TM, Hwang DW, Oh SW, Lee DS.
  
  Mol Imaging. 2014 Sep 1;13(0)1-12 PMID:25249435
49
- 49
- In Vivo bioluminescence imaging for prolonged survival of transplanted human neural stem cells using 3D biocompatible scaffold in corticectomized rat model.
  
  Hwang do W, Jin Y, Lee do H, Kim HY, Cho HN, Chung HJ, Park Y, Youn H , Lee SJ, Lee HJ, Kim SU, Wang KC, Lee DS.
  
  PLoS One. 2014 Sep 8;9(9):e105129 PMID:25198726
48
- 48
- The Intratumoral administration of ferucarbotran conjugated with doxorubicin improved therapeutic effect by magnetic hyperthermia combined with pharmacotherapy in a hepatocellular carcinoma model.
  
  Jeon M, Ahn CH, Kim H, Chung IJ, Jung S, Kim YH, Youn H , Chung J, Kim Y.
  
  J Exp Clin Cancer Res. 2014 Jul 18;33(1):57 PMID:25037747
47
- 47
- Enhanced Efficacy of CKD-516 in Combination with Doxorubicin: Pre-clinical Evaluation Using a Hepatocellular Carcinoma Xenograft Model.
  
  Kim YI, Kim KW, Lee HK, Park J, Chung JW, Youn H , Kim SJ, Kim DH, Tseng JC, Lee JM.
  
  Anticancer Res 2014 Apr; 34(4):1715-22. PMID:24692701
46
- 46
- In Vivo Brain Delivery of v-myc Overproduced Human Neural Stem Cells via the Intranasal Pathway: Tumor Characteristics in the Lung of a Nude Mouse.
  
  Lee ES, Im HJ, Kim HS, Youn H , Lee HJ, Kim SU, Hwang do W, Lee DS
  
  Molecular Imaging 2014 Mar1;13(0)1-10 (IF 2.191) PMID:25743637
45
- 45
- Preclinical evaluation of isostructural Tc-99m- and Re-188-folate-Gly-Gly-Cys-Glu for folate receptor-positive tumor targeting.
  
  Kim WH, Kim CG , Kim MH, Kim DW, Park CR, Park JY, Lee YS, Youn H, Kang KW, Jeong JM, Chung JK. PMID: 26993818
  
  Ann Nucl Med. 2016 Jun;30(5):369-79.
44
- 44
- A new fluorescence/PET probe for targeting intracellular human telomerase reverse transcriptase (hTERT) using Tat peptide-conjugated IgM.
  
  Jung KO, Youn H , Kim SH, Kim YH, Kang KW, Chung JK . PMID: 27317485
  
  Biochem Biophys Res Commun. 2016 Aug 26;477(3):483-9.
43
- 43
- Dihydropyrimidine Dehydrogenase Is a Prognostic Marker for Mesenchymal Stem Cell-Mediated Cytosine Deaminase Gene and 5-Fluorocytosine Prodrug Therapy for the Treatment of Recurrent Gliomas.
  
  Chung T, Na J, Kim YI, Chang DY, Kim YI, Kim H, Moon HE, Kang KW, Lee DS, Chung JK , Kim SS, Suh-Kim H, Paek SH, Youn H . PMID: 27446484
  
  Theranostics. 2016 Jun 17;6(10):1477-90.
42
- 42
- Peptidyl Prolyl Isomerase PIN1 Directly Binds to and Stabilizes Hypoxia-Inducible Factor-1α.
  
  Han HJ, Kwon N, Choi MA, Jung KO, Piao JY, Ngo HK, Kim SJ, Kim DH, Chung JK, Cha YN, Youn H, Choi BY, Min SH, Surh YJ. PMID: 26784107
  
  PLoS One. 2016 Jan 19;11(1):e0147038.
41
- 41
- Targeting BRG1 chromatin remodeler via its bromodomain for enhanced tumor cell radiosensitivity in vitro and in vivo.
  
  Kwon SJ, Lee SK, Na J, Lee SA, Lee HS, Park JH, Chung JK, Youn H, Kwon J . PMID: 25504753
  
  Mol Cancer Ther. 2015 Feb;14(2):597-607.
40
- 40
- Codon-optimized human sodium iodide symporter (opt-hNIS) as a sensitive reporter and efficient therapeutic gene.
  
  Kim YH, Youn H , Na J, Hong KJ, Kang KW, Lee DS, Chung JK . PMID: 25553100
  
  Theranostics. 2015 Jan 1;5(1):86-96.
39
- 39
- Interaction of tetraspan(in) TM4SF5 with CD44 promotes self-renewal and circulating capacities of hepatocarcinoma cells.
  
  Lee D, Na J, Ryu J, Kim HJ, Nam SH, Kang M, Jung JW, Lee MS, Song HE, Choi J, Lee GH, Kim TY, Chung JK, Park KH, Kim SH, Kim H, Seo H, Kim P, Youn H, Lee JW . PMID: 25627085
  
  Hepatology. 2015 Jun;61(6):1978-97.

게시물 검색 검색대상 검색어 필수

Family Site

서울특별시 종로구 대학로 101 (연건동 28)
진료예약안내 | 1588-5700

환자권리장전

서울대학교병원은 환자중심,인간존중,지식창조,사회봉사라는 경영이념을 통해 신체적/정신적 어려움으로 병원을 찾는 모든 환자의 권리를 존중하고, 최선의 진료를 제공하기 위하여 다음과 같이 선언한다.

존엄의 권리

환자는 존엄한 인간으로서 예우받을 권리가 있다.

평등의 권리

환자는 성별, 연령, 종교 또는 사회적 신분을 떠나 평등한 진료를 받을 권리가 있다.

설명을 들을 권리

환자는 의료진으로부터 질병의 진단,치료계획,결과,예후에 대한 설명을 들을 권리가 있다.

선택의 권리

환자는 치료,검사,수술,입원 등 본인에게 이루어지는 의료행위에 대한 설명을 듣고 시행여부를 선택할 권리가 있다.

개인신상 비밀을 보호받을 권리

환자는 진료내용,신체의 비밀 및 개인생활의 비밀을 보호받을 권리가 있다.

목록